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Partial left ventriculectomy (PLV) has been introduced totreat end-stage cardiomyopathy but has not achieved afavorable outcome. We thought it important to preservecardiac muscle possessing the potential power source of
the left ventricle and to avoid resection of the left circumflex
coronary artery. From this viewpoint, we developed a new oper-
ative procedure of left ventricular (LV) volume reduction without
any resection of cardiac muscle and have confirmed its beneficial
effect in a canine model. This is the first clinical report of this new
procedure.
Clinical Summary
A 62-year-old man with dilated cardiomyopathy (DCM) was re-
ferred to our institution in August 2001. Since 1995, he has been
treated with medication, including -blockers, for DCM with mild
mitral and aortic regurgitation confirmed by endocardial biopsy.
However, he had orthopnea (New York Heart Association class
III) in May 2001, when echocardiography demonstrated an ejec-
tion fraction (EF) of 23% with severe mitral and moderate aortic
and tricuspid regurgitation. In July 2001, he required direct-current
shock to be resuscitated from an arrhythmia. Preoperative catheter
laboratory study showed mean pulmonary wedge pressure of 12
mm Hg, LV end-diastolic pressure of 18 mm Hg, cardiac index of
1.86 L  min–1  m–2, LV end-diastolic volume of 182 mL, LV
end-systolic volume of 137 mL, EF of 24%, and intact coronary
arteries.
The operation was performed on August 4. Informed consent
was obtained before the operation. The operative procedure in-
cluded replacement of the thickened aortic valve with myxoid
change with a 21 Carpentier-Edwards pericardial valve, annulo-
plasty of a simply dilated mitral anulus with a 26 Carpentier
Physioring, tricuspid annuloplasty with a 30 Cosgrove ring (Baxter
Healthcare Corporation, Irvine, Calf), and our original LV reduc-
tion operation, termed overlapping cardiac volume reduction op-
eration (OLCVR). OLCVR consisted of the following 3 steps: (1)
a transmural longitudinal incision along the left anterior descend-
ing artery in the enlarged LV free wall; (2) continuous sutures of
the left incision marginal to the endocardium of the septal wall;
and (3) interrupted sutures of the right incision marginal to the
ventricular free wall (Figures 1 and 2). It took about 30 minutes to
complete the OLCVR procedure. Cardiopulmonary bypass was
conducted under mild hypothermia with antegrade and retrograde
intermittent cold blood cardioplegia. Weaning from cardiopulmo-
nary bypass was easy after a 121-minute crossclamping period.
Results
The patient recovered uneventfully and was extubated 4 hours
after the operation. Two weeks’ postoperative catheter study
showed mean pulmonary wedge pressure of 7 mm Hg, cardiac
index of 2.93 L  min–1  m–2, LV end-diastolic volume of 141 mL,
LV end-systolic volume of 87 mL, and EF of 38% without damage
to coronary arteries. He was discharged 26 days after the operation
and has been doing well in New York Heart Association class I for
7 months without any troublesome arrhythmias.
Discussion
The primary objective of PLV is to decrease LV wall tension on
the basis of Laplace’s law1 under the premise that remaining
cardiac muscle is viable. However, prediction of the viability of
cardiac muscle is often difficult, and PLV would worsen LV
function if the resected area included the most viable muscles.2
Another problem is that PLV is associated with the resection of the
obtuse marginal circumflex coronary artery, which might lead to
myocardial ischemia, causing postoperative arrhythmia.4 Recent
series of PLV have shown a high operative mortality, high inci-
dence of recurrence of heart failure, and arrhythmia-related
deaths.3
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Our new procedure, OLCVR, has a couple of merits when
compared with the traditional PLV, namely preservation of cardiac
muscle and preservation of the circumflex coronary artery. These
merits might be better suited to preserve LV contractility and to
avoid LV ischemia than PLV, which might lead to a better out-
come. The other presumable merits might include that (1) OLCVR
might be a reversible procedure when the overlapping portion is
too excessive; (2) the overlapping portion of cardiac muscle might
have a girdling effect in the long-term period, as well as during
cardiomyoplasty4; and (3) the excluded portion (a part of septum
and anterior muscle) does not undergo direct pressure from the
inside of the heart and therefore might possess a potential ability to
support cardiac function, as well as cardiomyoplasty with the
latissimus dorsi.5
Because we performed aortic, mitral, and tricuspid valve sur-
gery in addition to OLCVR, the drastic improvement of the pa-
tient’s condition might not result from OLCVR only. However,
mitral reconstruction would be beneficial for patients with DCM
and viable myocardium but without severely deteriorated LV
function.1 According to preoperative deteriorated LV functions,
OLCVR must be beneficial for the rapid recovery of cardiac
function and might save medical expenses in our case. Although
long-term follow-up is mandatory, OLCVR might become a ther-
apeutic option for end-stage cardiomyopathy.
Figure 2. Intraoperative view of OLCVR. Left, Continuous sutures of the left incision marginal to the septal wall.
Right, Pledget-supported mattress sutures of the right incision marginal which vessels were cauterized electri-
cally to the LV free wall.
Figure 1. Operative procedures of OLCVR. Left, A transmural longitudinal incision along with the left anterior
descending branch in the enlarged LV free wall. Middle, Continuous sutures of the left incision marginal to the
endocardium of the septal wall. Right, Interrupted sutures of the right incision marginal to the LV free wall.
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